Welcome to the Investor Portal
Access Fund I information, documents, and updates
Fund I Overview
Formation-stage venture capital fund focused on space, defense, and dual-use technologies
across Five Eyes nations (Canada, USA, UK, Australia, New Zealand).
Jan 28
Target First Close
Fund Documents
📄
Investment Memorandum
Comprehensive overview of Fund I strategy, thesis, team, and terms
PDF • Updated Dec 2024 • 32 pages
Download PDF
📋
Limited Partnership Agreement
Legal partnership agreement for Fund I limited partners
PDF • Updated Dec 2024 • 48 pages
Download PDF
✍️
Subscription Documents
Subscription agreement and investor qualification forms
PDF Package • Updated Dec 2024
Download Package
📊
Fund I Presentation
Investor presentation deck with strategy and market analysis
PPTX • Updated Dec 2024 • 28 slides
Download Deck
🔍
Due Diligence Package
Background checks, references, and compliance documentation
ZIP Archive • Updated Dec 2024
Download Archive
⚖️
Legal & Regulatory
Regulatory filings, registrations, and compliance documents
PDF Package • Updated Dec 2024
Download Package
Recent Updates
December 14, 2024
London Fundraising Trip Scheduled
We're pleased to announce meetings scheduled with UK-based institutional investors including
sovereign wealth funds (Mubadala Capital Ventures) and government programs (NATO Innovation Fund)
for January 28, 2025. This represents a significant milestone in our Fund I capital raise.
December 10, 2024
Hard Commitments Update: $1.45M
Fund I has secured $1.45M in hard commitments toward our $2.5M target. We're on track for
our first close by January 28, 2025. Thank you to our early committed LPs for their confidence
in the HUMANUS.VC thesis.
November 28, 2024
Legal Counsel Retained: Osler, Hoskin & Harcourt LLP
We've engaged Osler, Hoskin & Harcourt LLP as legal counsel for Fund I formation and
cross-border compliance. Osler brings deep expertise in Canadian venture capital fund
formation and multi-jurisdiction securities law.
⚠️ Confidential Information Notice
All information contained in this portal is confidential and proprietary to HUMANUS.VC.
This material is provided solely for your evaluation as a potential limited partner. It may not be
reproduced, distributed, or disclosed to any third party without express written consent from HUMANUS.VC.
By accessing this portal, you acknowledge that you are an accredited investor or qualified person under
applicable securities laws and agree to maintain the confidentiality of all information provided.
The securities described herein have not been registered under the U.S. Securities Act of 1933,
the securities laws of any Canadian province or territory, or the laws of any other jurisdiction.
Investment in the fund involves significant risk and is suitable only for sophisticated investors
who can afford the loss of their entire investment.
